Cardinal Health, Inc. $CAH Shares Sold by Simplify Asset Management Inc.

Simplify Asset Management Inc. decreased its stake in Cardinal Health, Inc. (NYSE:CAHFree Report) by 47.4% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 12,223 shares of the company’s stock after selling 11,006 shares during the period. Simplify Asset Management Inc.’s holdings in Cardinal Health were worth $1,912,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Geode Capital Management LLC boosted its stake in shares of Cardinal Health by 3.3% during the 2nd quarter. Geode Capital Management LLC now owns 6,389,049 shares of the company’s stock worth $1,069,005,000 after acquiring an additional 205,539 shares in the last quarter. Norges Bank purchased a new position in shares of Cardinal Health in the second quarter valued at $584,420,000. Invesco Ltd. raised its stake in shares of Cardinal Health by 7.3% during the 2nd quarter. Invesco Ltd. now owns 3,037,782 shares of the company’s stock worth $510,347,000 after buying an additional 207,750 shares during the last quarter. Legal & General Group Plc grew its stake in Cardinal Health by 2.0% in the 2nd quarter. Legal & General Group Plc now owns 2,349,767 shares of the company’s stock valued at $394,761,000 after acquiring an additional 45,812 shares during the last quarter. Finally, Marshall Wace LLP increased its holdings in Cardinal Health by 19.1% during the 2nd quarter. Marshall Wace LLP now owns 1,930,967 shares of the company’s stock valued at $324,402,000 after acquiring an additional 309,335 shares in the last quarter. 87.17% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several analysts have recently commented on CAH shares. UBS Group increased their price target on shares of Cardinal Health from $185.00 to $220.00 and gave the company a “buy” rating in a research report on Friday, October 31st. Mizuho increased their price target on Cardinal Health from $170.00 to $210.00 and gave the stock an “outperform” rating in a research note on Monday, November 3rd. Argus raised their target price on shares of Cardinal Health from $189.00 to $211.00 and gave the stock a “buy” rating in a research report on Tuesday, November 4th. Wells Fargo & Company increased their target price on Cardinal Health from $185.00 to $221.00 and gave the stock an “overweight” rating in a research report on Wednesday, November 5th. Finally, Deutsche Bank Aktiengesellschaft lifted their price objective on Cardinal Health from $195.00 to $208.00 and gave the company a “hold” rating in a research note on Tuesday, November 18th. Thirteen research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. According to MarketBeat.com, Cardinal Health currently has a consensus rating of “Moderate Buy” and an average price target of $209.00.

Check Out Our Latest Stock Report on CAH

Cardinal Health Stock Down 0.5%

Shares of CAH opened at $207.19 on Tuesday. The firm has a market cap of $49.23 billion, a price-to-earnings ratio of 31.25, a PEG ratio of 1.52 and a beta of 0.63. The business’s 50 day moving average is $197.29 and its two-hundred day moving average is $170.59. Cardinal Health, Inc. has a 52-week low of $117.53 and a 52-week high of $214.93.

Cardinal Health (NYSE:CAHGet Free Report) last posted its quarterly earnings data on Thursday, October 30th. The company reported $2.55 EPS for the quarter, beating analysts’ consensus estimates of $2.22 by $0.33. The firm had revenue of $64.01 billion for the quarter, compared to the consensus estimate of $59.41 billion. Cardinal Health had a net margin of 0.68% and a negative return on equity of 84.37%. The firm’s revenue was up 22.4% compared to the same quarter last year. During the same period in the prior year, the firm posted $1.88 EPS. Cardinal Health has set its FY 2026 guidance at 9.650-9.850 EPS. On average, equities analysts expect that Cardinal Health, Inc. will post 7.95 earnings per share for the current fiscal year.

Cardinal Health Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Thursday, January 15th. Stockholders of record on Friday, January 2nd will be given a $0.5107 dividend. The ex-dividend date is Friday, January 2nd. This represents a $2.04 annualized dividend and a dividend yield of 1.0%. Cardinal Health’s dividend payout ratio (DPR) is presently 30.77%.

Cardinal Health Company Profile

(Free Report)

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.

Featured Articles

Want to see what other hedge funds are holding CAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardinal Health, Inc. (NYSE:CAHFree Report).

Institutional Ownership by Quarter for Cardinal Health (NYSE:CAH)

Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.